002788SZSE

Summary of the 2025 Annual Report

Luyan Pharmaceutical Co., Ltd.··7p

✨ AI Summary

This 2025 annual report provides an overview of Shenzhen Medical's operations, financial status, and future plans. Key financial data shows Total Assets at 13,395,732.01 and Total Revenue at 21,216,784.96. The company's primary business involves the production and sale of medical products and services. The report confirms the company has undergone its annual audit and complied with regulations.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openaiSign In to Upgrade

I. Important Notice

This annual report is prepared in accordance with the requirements of the annual report. To provide a comprehensive understanding of the company's operational results, financial status, and future development plans, investors are encouraged to review the entire annual report.

II. Basic Information of the Company

  1. Company Overview
Stock NameShenzhen MedicalStock Code002788
Registered OfficeShenzhen CityLegal Representative[blank]
Address[blank]Fax0592-8129130
Phone0592-8129338Emailzqb@luyuan.com.cn
  1. Key Business Information

The company's main business includes the production and sale of medical products and services, with a focus on healthcare.

III. Key Financial Data and Financial Indicators

  1. Key Financial Data and Financial Indicators
Item202320242025Year-on-Year Change
Total Assets13,395,732.0112,638,595.9413,395,732.0111,793,594.161.35
Total Revenue21,216,784.9620,470,766.0421,216,784.9619,845,634.615.24
  1. Quarterly Key Financial Data
ItemFirst QuarterSecond QuarterThird QuarterFourth Quarter
Revenue5,173,736.3065,226,325.9875,455,376.4815,391,236.184

IV. Stock and Shareholder Situation

  1. General Stock Situation
ItemNumber of SharesShareholder Structure
Total Shares78,92969,466

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Notes & Comments

Sign in to leave a comment or private note.

Loading…

Summary of the 2025 Annual Report — Luyan Pharmaceutical Co., Ltd. | SZSE Releases